Journal Article Semaphorin 4D promotes bone invasion in head and neck squamous cell carcinoma

Takada, Hiroyuki  ,  Ibaragi, Soichiro  ,  Eguchi, Takanori  ,  Okui, Tatsuo  ,  Obata, Kyoichi  ,  Masui, Masanori  ,  Morisawa, Ayaka  ,  Takabatake, Kiyofumi  ,  Kawai, Hotaka  ,  Yoshioka, Norie  ,  Nur Mohammad Monsur Hassan,  ,  Shimo, Tsuyoshi  ,  Hu, Guo-Fu  ,  Nagatsuka, Hitoshi  ,  Sasaki, Akira

51 ( 2 )  , pp.625 - 632 , 2017-06-21 , Spandidos Publications
Head and neck squamous cell carcinomas (HNSCCs) frequently invade the bones of the facial skeleton. Semaphorin 4D (Sema4D) is an axon guidance molecule produced by oligodendrocytes. Sema4D was also identified in the bone microenvironment and many cancer tissues including HNSCC. To date, however, the role of Sema4D in cancer-associated bone disease is still unknown. This is the first study to demonstrate the role of Sema4D in bone invasion of cancer. In the clinical tissue samples of bone lesion of HNSCC, Sema4D was detected at high levels, and its expression was correlated with insulin-like growth factor-I (IGF-I) expression. In vitro experiments showed that IGF-I regulates Sema4D expression and Sema4D increased proliferation, migration and invasion in HNSCC cells. Sema4D also regulated the expression of receptor activator of nuclear factor κβ ligand (RANKL) in osteoblasts, and this stimulated osteoclastgenesis. Furthermore, knockdown of Sema4D in HNSCC cells inhibited tumor growth and decreased the number of osteoclasts in a mouse xenograft model. Taken together, IGF-I-driven production of Sema4D in HNSCCs promotes osteoclastogenesis and bone invasion.

Number of accesses :  

Other information